Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial
Wendy Landier, Smita Bhatia, F. Lennie Wong, Jocelyn M. York, Jessica S. Flynn, Harrison Henneberg, Purnima Singh, Kandice Adams, Karen Wasilewski‐Masker, Brooke Cherven, Rama Jasty‐Rao, Marcia Leonard, James A. Connelly, Saro H. Armenian, Leslie L. Robison, Anna R. Giuliano, Melissa M. Hudson, James L. Klosky
Topics & Concepts
MedicineImmunogenicityCancerPopulationHPV vaccinesClinical trialYoung adultCervical cancerGardasilInternal medicineVaccinationClinical endpointOncologyHPV infectionImmunologyAntibodyEnvironmental healthCervical Cancer and HPV ResearchHead and Neck Cancer StudiesLymphadenopathy Diagnosis and Analysis